SCHEMBL21940283

SCHEMBL21940283

Cn1cc(-c2nnc(CN)cc2N2CC(F)(F)C2)c(C(F)(F)F)n1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 1/20 0.37
▸ PRMT5 O14744 1/20 0.37
▸ WDR77 Q9BQA1 1/20 0.37
▸ S1PR2 O95136 13/20 0.37
▸ CYP2C19 P33261 2/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ BACE1 P56817 1/20 0.32
▸ BACE2 Q9Y5Z0 1/20 0.32
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ CDK2 P24941 1/20 0.31
▸ FLT3 P36888 1/20 0.31
▸ CCNA1 P78396 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21941069 0.84 SOS1 (0.37) PRMT5WDR77S1PR2CYP2C19CYP3A4
SCHEMBL21940285 0.80 S1PR2 (0.40) IDH1S1PR2CYP2C19CYP3A4ALDH1A1
SCHEMBL20606921 0.79 S1PR2 (0.49) PRMT5WDR77S1PR2CYP2C19CYP3A4
Hydrochloric Acid SCHEMBL20606941 0.78 S1PR2 (0.48) PRMT5WDR77S1PR2CYP2C19CYP3A4
SCHEMBL21819818 0.76 PRMT5 (0.39) IDH1PRMT5WDR77S1PR2CYP2C19
SCHEMBL21941072 0.76 S1PR2 (0.41) PRMT5WDR77S1PR2CYP2C19CYP3A4
SCHEMBL21940289 0.76 PRMT5 (0.40) IDH1PRMT5WDR77S1PR2CYP2C19
SCHEMBL21940575 0.74 S1PR2 (0.39) PRMT5WDR77S1PR2CYP2C19CYP3A4
SCHEMBL21940577 0.68 PRMT5 (0.45) PRMT5WDR77S1PR2CYP2C19CYP3A4
SCHEMBL21940505 0.63 CHRM4 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3423445-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS GALAPAGOS NV (BE) 2020-04-01 — — EP disclosed
Send feedback